[HTML][HTML] Mapping factors that affect the uptake of digital therapeutics within health systems: scoping review

R van Kessel, A Roman-Urrestarazu… - Journal of Medical …, 2023 - jmir.org
Background Digital therapeutics are patient-facing digital health interventions that can
significantly alter the health care landscape. Despite digital therapeutics being used to …

[HTML][HTML] Digital health reimbursement strategies of 8 European countries and Israel: scoping review and policy mapping

R van Kessel, D Srivastava, I Kyriopoulos… - JMIR mHealth and …, 2023 - mhealth.jmir.org
Background: The adoption of digital health care within health systems is determined by
various factors, including pricing and reimbursement. The reimbursement landscape for …

[HTML][HTML] Digital health applications (DiGAs) on a fast track: insights from a data-driven analysis of prescribable digital therapeutics in Germany from 2020 to mid-2024

M Goeldner, S Gehder - Journal of Medical Internet Research, 2024 - jmir.org
Background This study aimed to analyze the rapidly evolving ecosystem of digital health
applications (Digitale Gesundheitsanwendung; DiGAs) in Germany, spurred by the 2019 …

Towards harmonizing assessment and reimbursement of digital medical devices in the EU through mutual learning

R Tarricone, F Petracca, HM Weller - NPJ Digital Medicine, 2024 - nature.com
Digital medical devices (DMDs) present unique opportunities in their regulation and
reimbursement. A dynamic landscape of DMD assessment frameworks is emerging within …

Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation

B Freitag, M Uncovska, S Meister, C Prinz… - npj Digital …, 2024 - nature.com
Regulated mobile health applications are called digital health applications (“DiGA”) in
Germany. To qualify for reimbursement by statutory health insurance companies, DiGA have …

Covering digital health applications in the public insurance system: how to foster innovation in patient care while mitigating financial risks—evidence from Germany

N Groene, L Schneck - Frontiers in Digital Health, 2023 - frontiersin.org
Context Digital health applications that support patients in managing their condition can
have a positive impact on patients' health and improve the overall care process. In late 2019 …

Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial

LT Betz, GA Jacob, J Knitza, M Koehm… - npj Mental Health …, 2024 - nature.com
Cognitive behavioral therapy improves psychosocial outcomes in rheumatoid arthritis (RA),
but access is limited. We conducted a randomized controlled trial to evaluate the efficacy of …

Design and features of pricing and payment schemes for health technologies: A scoping review and a proposal for a flexible need-driven classification

V Ardito, O Ciani, M Drummond - PharmacoEconomics, 2024 - Springer
Abstract Background and Objective In a context of growing clinical and financial uncertainty,
pricing and payment schemes can act as possible solutions to the problems of affordability …

[HTML][HTML] Digital health applications from a government-regulated directory of reimbursable health apps in Germany—a systematic review for evidence and bias

F Dittrich, A Mielitz, E Pustozerov, D Lawin, U von Jan… - Mhealth, 2023 - ncbi.nlm.nih.gov
Background The Digital Healthcare Act, passed in November 2019, authorizes healthcare
providers in Germany to prescribe digital health applications (DiGA) to patients covered by …

The three-year evolution of Germany's Digital Therapeutics reimbursement program and its path forward

L Schmidt, M Pawlitzki, BY Renard, SG Meuth… - NPJ Digital …, 2024 - nature.com
Abstract The 2019 German Digital Healthcare Act introduced the Digital Health Application
program, known in German as 'Digitale Gesundheitsanwendungen'(DiGA). The program has …